Searched for
6 APA
Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...- Market bets on Aurobindo as Europe, US sales show uptickAurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also develop...
- Expects Pen-G production capacity to touch 10k metric tonnes in 12 months: Aurobindo PharmaAurobindo Pharma is set to boost Penicillin-G output to over 10,000 metric tonnes annually. Its China manufacturing facility is projected t...
- Minimum import price set for Penicillin G, saltsThe Indian government has imposed a minimum import price on crucial pharmaceutical ingredients like penicillin G, amoxicillin, and 6-APA. T...
- Experts warn of risks from govt price floor on key pharma inputsThe government has proposed to impose MIP on Penicillin-G (Pen-G), with possible extension to 6-aminopenicillanic acid (6-APA) and amoxicil...
- Pharma industry warns minimum import prices plan could raise drug prices, hurt MSMEsPharma experts have flagged concerns over the government’s plan to set minimum import prices (MIP) for key drug ingredients such as Penicil...
- Import price floor on cards for critical pharma inputsIndia is setting a minimum import price for essential drug ingredients. This move aims to shield local manufacturers from cheap imports, pa...
- Aurobindo Pharma commissions four plants in Andhra Pradesh including Pen-G facilityThe Rs 2,400 crore Pen-G plant is expected to start trial production in April and commercial production in a couple of months and the rampi...
- Budget has to fix Indian taxpayers' nagging dispute management issue for realUnion Budget 2023: The multiple initiatives announced clearly reflect the government’s intent to address the malaise. However, on-the-groun...
- Bopanna and Mirza out of Australia Open men's and women's doublesThe two Indians are, however, still alive in the first Grand Slam of the season as they will compete in the mixed doubles.
- Australian shares recoup losses, end higher on energy boostEnergy stocks added nearly 1.5% - their best session in a week - as oil prices jumped on signs of U.S. supply tightness.
- Feeling stressed? Put your smartphone downThe attachment to devices and the constant use of technology is associated with higher stress levels, researchers found.
- CBDT inks ‘rollback’ advance pricing agreement with US MNC; 8 more deals likelyThe ‘rollback’ advance pricing agreement (APA) was signed between a US multinational and the tax department at about 6 pm on Monday.
- Antibiotics may get costlierThe government may levy duty on two important drug ingredients imported from China and Mexico to protect local suppliers.
- Prices of antibiotics may flare up 50%A government proposal to slap anti-dumping duties on Chinese and Mexican imports of two key pharma ingredients will push up the prices of c...
- Pharma industry against safeguard duty on Chinese antibioticsThe small pharmaceutical industry is opposed to imposition of safeguard duty on import of antibiotic bulk drugs 6APA and erythromycin from ...
- Safeguard duty on penicillin raw materialsGovernment is planning to start investigations into imports of 6APA and erythromycin- raw materials used for making antibiotics- from China.
- Atlas Cycles, Shanku lead charge into pharma sectorThe pharmaceutical sector-an area largely insulated from the downturn-is attracting companies from other sectors.
- Qantas bid hits air pocket as regulator refuses extensionAustralia’s takeover regulator has scuttled an A$11 billion ($9 billion) bid for Qantas Airways after refusing on Sunday to allow late supp...
- Qantas takeover blocked by regulatorThe panel rejected an application by the bid group, Airline Partners Australia (APA).
Load More
